Teva-discovered TEV-’408 targets IL-15, a key driver of vitiligo biology TEV-’408 showed improvement in skin pigmentation and was well-tolerated with no safety signals observed to dateNearly 75% of pa ...
Key Takeaways Fatty liver disease can fuel the most aggressive form of colon cancerPeople with fatty liver are more likely to ...